시장보고서
상품코드
1766583

국소 진통제 시장 : 제품 유형별, 유효 성분별, 유형별, 용도별, 환자층별, 유통 채널별, 지역별

Topical Pain Relief Market, By Product Type, By Active Ingredient, By Type, By Application, By Patient Demographics, By Distribution Channel, By Geography

발행일: | 리서치사: Coherent Market Insights | 페이지 정보: 영문 | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

국소 진통제 시장은 2025년에는 111억 달러로 추정되며, 2032년에는 159억 3,000만 달러에 달할 것으로 예측되며, 2025년부터 2032년까지 연평균 성장률(CAGR) 5.3%로 성장할 전망입니다.

보고서 범위 보고서 상세
기준 연도 2024년 2025년 시장 규모 111억 달러
실적 데이터 2020-2024년 예측 기간 2025-2032년
예측 기간 : 2025-2032년 CAGR 5.30% 2032년 가치 예측 159억 3,000만 달러

세계 국소 진통제 시장은 만성 통증 질환의 유병률 증가, 노인 인구 증가, 국소 통증 관리 솔루션의 이점에 대한 인식 증가 등으로 인해 최근 몇 년 동안 큰 성장세를 보이고 있습니다. 국소 진통제 제품은 유효 성분을 환부에 직접 투여하여 국소적인 통증 완화를 제공하고 전신 노출을 최소화하며 경구용 진통제의 부작용 위험을 줄입니다. 이 시장에는 비스테로이드성 항염증제(NSAIDs), 멘톨, 캡사이신, 리도카인 등 다양한 유효 성분을 함유한 크림, 젤, 스프레이, 패치, 연고 등 다양한 제품이 있습니다. 급성 및 만성 통증 관리를 위해 안전하고 효과적인 대안을 찾는 소비자가 증가함에 따라 국소 진통제에 대한 수요는 지속적으로 증가할 것으로 예상됩니다.

시장 역학

세계 국소 진통제 시장은 장기적인 통증 관리 솔루션을 필요로 하는 관절염, 요통, 스포츠 부상과 같은 만성 통증 증상의 유병률 증가 등 여러 요인에 의해 주도되고 있습니다. 또한, 노인들은 만성 통증 상태에 빠지기 쉽기 때문에 전 세계 노인 인구의 증가도 시장 성장에 기여하고 있습니다. 또한, 경구용 진통제의 부작용에 대한 인식이 높아지면서 전신에 미치는 영향을 최소화하면서 국소적인 통증 완화를 위한 국소 진통제로 소비자의 선호도가 변화하고 있습니다. 그러나 경구용 약물이나 물리치료와 같은 대체 통증 관리 옵션의 가용성과 일부 국소용 제품의 중증 통증 상태에 대한 제한적인 효과로 인해 시장 성장을 저해할 수 있습니다. 또한, 새로운 통증 완화 외용제 승인에 대한 엄격한 규제 지침은 시장 진입자들에게 도전이 될 수 있습니다. 이러한 시장 억제요인에도 불구하고, 천연 소재 및 유기농 통증 완화 제품에 대한 수요 증가, 새로운 약물전달 시스템의 시장 개척, E-Commerce 플랫폼을 포함한 유통 채널의 확대는 시장에 큰 성장 기회를 가져다 줄 것으로 예상됩니다.

본 조사의 주요 특징

  • 세계의 국소 진통제 시장에 대해 조사분석했으며, 2024년을 기준 연도로 하여 예측 기간(2025-2032년) 동안의 시장 규모(10억 달러)와 연평균 성장률(CAGR)을 조사하여 전해드립니다.
  • 또한, 다양한 부문에 걸친 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
  • 또한 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략 등에 대한 중요한 인사이트를 제공합니다.
  • 이 보고서는 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 성과, 전략 등의 매개 변수를 기반으로 세계 국소 진통제 시장의 주요 기업 프로파일을 제공합니다.
  • 이 보고서의 인사이트를 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형화, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
  • 이 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
  • 이해관계자들은 세계 국소 진통제 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있습니다.

목차

제1장 조사 목적과 가정

  • 조사 목적
  • 가정
  • 약어

제2장 시장 전망

  • 보고서 설명
    • 시장 정의와 범위
  • 주요 요약

제3장 시장 역학, 규제, 동향 분석

  • 시장 역학
  • 성장 촉진요인
  • 성장 억제요인
  • 기회
  • 영향 분석
  • 주요 발전
  • 규제 시나리오
  • 제품 발매/승인
  • PEST 분석
  • PORTER의 분석
  • 인수합병 시나리오
  • 업계 동향

제4장 세계의 국소 진통제 시장, 제품 유형별, 2020-2032년

  • 크림
  • 연고
  • 패치
  • 스프레이
  • 롤온

제5장 세계의 국소 진통제 시장, 유효 성분별, 2020-2032년

  • 비스테로이드성 항염증제(NSAID)
  • 항자극제
  • 마취제
  • 살리실산염
  • 캡사이신
  • 멘톨

제6장 세계의 국소 진통제 시장, 유형별, 2020-2032년

  • 처방 진통제
  • 시판 진통제

제7장 세계의 국소 진통제 시장, 용도별, 2020-2032년

  • 관절염 통증
  • 근육과 관절 통증
  • 요통
  • 스포츠 부상
  • 신경병증성 통증
  • 수술 후 통증

제8장 세계의 국소 진통제 시장, 환자층별, 2020-2032년

  • 성인
  • 노인
  • 소아

제9장 세계의 국소 진통제 시장, 유통 채널별, 2020-2032년

  • 온라인 약국
  • 소매 약국
  • 병원 약국
  • 슈퍼마켓/하이퍼마켓
  • 건강과 웰니스 스토어

제10장 세계의 국소 진통제 시장, 지역별, 2020-2032년

  • 북미
      • 미국
      • 캐나다
  • 라틴아메리카
      • 브라질
      • 아르헨티나
      • 멕시코
      • 기타 라틴아메리카
  • 유럽
      • 독일
      • 영국
      • 스페인
      • 프랑스
      • 이탈리아
      • 러시아
      • 기타 유럽
  • 아시아태평양
      • 중국
      • 인도
      • 일본
      • 호주
      • 한국
      • ASEAN
      • 기타 아시아태평양
  • 중동
      • GCC 국가
      • 이스라엘
      • 기타 중동
  • 아프리카
      • 남아프리카공화국
      • 북아프리카
      • 중앙아프리카

제11장 경쟁 구도

  • Johnson & Johnson
  • Pfizer Inc.
  • GlaxoSmithKline
  • Bayer AG
  • Novartis AG
  • Sanofi S.A.
  • Merck & Co., Inc.
  • Abbott Laboratories
  • Amgen Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Astellas Pharma Inc.
  • Mylan N.V.
  • Reckitt Benckiser Group plc
  • Hisamitsu Pharmaceutical Co., Inc.
  • Mentholatum Company, Inc.

제12장 애널리스트의 추천사항

  • 기회
  • 애널리스트의 견해
  • Coherent Opportunity Map

제13장 참고문헌과 조사 방법

  • 참고문헌
  • 조사 방법
  • 출판사 소개
ksm 25.07.17

Topical Pain Relief Market is estimated to be valued at USD 11.10 Bn in 2025 and is expected to reach USD 15.93 Bn by 2032, growing at a compound annual growth rate (CAGR) of 5.3% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 11.10 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 5.30% 2032 Value Projection: USD 15.93 Bn

The global topical pain relief market has witnessed significant growth in recent years, driven by the increasing prevalence of chronic pain conditions, rising geriatric population, and growing awareness about the benefits of topical pain management solutions. Topical pain relief products offer localized pain relief by delivering active ingredients directly to the affected area, minimizing systemic exposure and reducing the risk of adverse effects associated with oral pain medications. The market encompasses a wide range of products, including creams, gels, sprays, patches, and ointments, formulated with various active ingredients such as non-steroidal anti-inflammatory drugs (NSAIDs), menthol, capsaicin, and lidocaine. The demand for topical pain relief products is expected to continue growing as more consumers seek safe and effective options for managing acute and chronic pain conditions.

Market Dynamics

The global topical pain relief market is driven by several factors, including the rising prevalence of chronic pain conditions, such as arthritis, back pain, and sports injuries, which require long-term pain management solutions. The growing geriatric population worldwide is also contributing to the market growth, as older adults are more susceptible to chronic pain conditions. Moreover, the increasing awareness about the side effects associated with oral pain medications has led to a shift in consumer preference towards topical pain relief products, which offer localized pain relief with minimal systemic exposure. However, the market growth may be restrained by the availability of alternative pain management options, such as oral medications and physical therapy, as well as the limited efficacy of some topical products for severe pain conditions. Additionally, stringent regulatory guidelines for the approval of new topical pain relief products may pose challenges for market players. Despite these restraints, the market presents significant opportunities for growth, driven by the increasing demand for natural and organic pain relief products, the development of novel drug delivery systems, and the expansion of distribution channels, including e-commerce platforms.

Key Features of the Study

  • This report provides in-depth analysis of the global topical pain relief market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global topical pain relief market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Johnson & Johnson, Pfizer Inc., GlaxoSmithKline, Bayer AG, Novartis AG, Sanofi S.A., Merck & Co., Inc., Abbott Laboratories, Amgen Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Mylan N.V., Reckitt Benckiser Group plc, Hisamitsu Pharmaceutical Co., Inc., and Mentholatum Company, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global topical pain relief market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global topical pain relief market.

Market Segmentation

  • Product Type Insights (Revenue, USD Bn, 2020 - 2032)
    • Gels
    • Creams
    • Ointments
    • Patches
    • Sprays
    • Roll-ons
  • Active Ingredient Insights (Revenue, USD Bn, 2020 - 2032)
    • Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
    • Counterirritants
    • Anesthetics
    • Salicylates
    • Capsaicin
    • Menthol
  • Type Insights (Revenue, USD Bn, 2020 - 2032)
    • Prescription Pain Relief
    • Over-the-Counter (OTC) Pain Relief
  • Application Insights (Revenue, USD Bn, 2020 - 2032)
    • Arthritis Pain
    • Muscle and Joint Pain
    • Back Pain
    • Sports Injuries
    • Neuropathic Pain
    • Post-Surgical Pain
  • Patient Demographics Insights (Revenue, USD Bn, 2020 - 2032)
    • Adults
    • Geriatrics
    • Pediatrics
  • Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
    • Online Pharmacies
    • Retail Pharmacies
    • Hospitals Pharmacy
    • Supermarkets/Hypermarkets
    • Health and Wellness Stores
  • Regional Insights (Revenue, USD Bn, 2020 - 2032)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Johnson & Johnson
    • Pfizer Inc.
    • GlaxoSmithKline
    • Bayer AG
    • Novartis AG
    • Sanofi S.A.
    • Merck & Co., Inc.
    • Abbott Laboratories
    • Amgen Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Astellas Pharma Inc.
    • Mylan N.V.
    • Reckitt Benckiser Group plc
    • Hisamitsu Pharmaceutical Co., Inc.
    • Mentholatum Company, Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Topical Pain Relief Market, By Product Type
    • Global Topical Pain Relief Market, By Active Ingredient
    • Global Topical Pain Relief Market, By Type
    • Global Topical Pain Relief Market, By Application
    • Global Topical Pain Relief Market, By Patient Demographics
    • Global Topical Pain Relief Market, By Distribution Channel
    • Global Topical Pain Relief Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Driver
  • Restraint
  • Opportunity
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Industry Trends

4. Global Topical Pain Relief Market, By Product Type, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Gels
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Creams
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Ointments
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Sprays
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Roll-ons
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Topical Pain Relief Market, By Active Ingredient, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Counterirritants
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Anesthetics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Salicylates
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Capsaicin
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Menthol
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Topical Pain Relief Market, By Type, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Prescription Pain Relief
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Over-the-Counter (OTC) Pain Relief
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Topical Pain Relief Market, By Application, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Arthritis Pain
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Muscle and Joint Pain
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Back Pain
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Sports Injuries
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Neuropathic Pain
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Post-Surgical Pain
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Topical Pain Relief Market, By Patient Demographics, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Adults
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Geriatrics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Pediatrics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Topical Pain Relief Market, By Distribution Channel, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Hospitals Pharmacy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Supermarkets/Hypermarkets
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Health and Wellness Stores
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

10. Global Topical Pain Relief Market, By Region, 2020 - 2032, Value (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Active Ingredient, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Patient Demographics, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Active Ingredient, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Patient Demographics, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Active Ingredient, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Patient Demographics, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Active Ingredient, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Patient Demographics, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Active Ingredient, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Patient Demographics, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Active Ingredient, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Patient Demographics, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

11. Competitive Landscape

  • Johnson & Johnson
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Pfizer Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • GlaxoSmithKline
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Bayer AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Novartis AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Sanofi S.A.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Merck & Co., Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Abbott Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Amgen Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Teva Pharmaceutical Industries Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Astellas Pharma Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Mylan N.V.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Reckitt Benckiser Group plc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Hisamitsu Pharmaceutical Co., Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Mentholatum Company, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

12. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

13. References and Research Methodology

  • References
  • Research Methodology
  • About us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제